|
Theo Wallimann (born October 13, 1946 in Alpnach, Obwalden, Switzerland), PhD, was a research group leader and Titular-Professor at the Institute of Cell Biology〔(''Homepage Wallimann Inst. Cell Biology'' )〕〔(''Homepage Wallimann Inst. Mol.Health Science'' )〕 of the ETH Zurich.〔( ''Homepage Wallimann Emeriti ETH Zürich'' )〕 In 1975, he completed his PhD Dissertation on "M-line-bound Creatine Kinase and Myofibrillar Structure"〔(M-line-bound Creatine Kinase and Myofibrillar Structure )〕 in the laboratory of Prof. Hans M. Eppenberger at the Institute of Cell Biology ETH Zurich with distinction and was awarded the ETH prize and medal. From 1975-1981, he worked as a post-doctoral research associate with Prof. Andrew G. Szent-Györgyi, 〔(Interview with Prof. Andrew G. Szent-Györgyi )〕 〔(Andrew Szent-Györgyi. Commemorative Symposium July 11th 2013 at the Marine Biological Laboratories (MBL) in Woods Hole )]〕 〔(Obituary for Andrew Szent-Györgyi, who passed away at 90 on Jan. 27th 2015 in Falmout, Mass. )〕 at the Biology Department of Brandeis University in Waltham, Massachusetts, U.S.A. on the subject of "Myosin-linked calcium regulation of muscle contraction". In 1981, he was appointed as senior researcher and group leader at the Institute of Cell Biology of the ETH Zurich to work and teach in the areas of muscle biochemistry, cellular bioenergetics and molecular structure and physiology of creatine kinases in health and disease. In 1984, he became a Lecturer (with Habilitation on "Localization and function of M-line-bound creatine kinase: M-band model and Phospho-Creatine Shuttle"〔(Function of M-line-bound creatine kinase: M-band model and Phospho-Creatine Shuttle" )〕) and in 1994, he was awarded the title of Professor. In 1995 and 1996 Wallimann was Head and Deputy Head of the Institute of Cell Biology, respectively. In 2005, Wallimann was awarded the Alfred-Vogt-Prize 2005.〔(''Alfred-Vogt Awardees'' )〕 Wallimann resigned from his post in June 2008 and is now Emeritus. == Research == Wallimann's main areas of interest are: *The structure, function, subcellular compartmentation and molecular physiology of creatine kinase (CK) isoenzymes and the Creatine Transporter (CRT), and in general, micro-compartmentation and metabolite channeling by multi-enzyme complexes. *The mechanisms of the cell enhancing and neuro-protective effects of creatine supplementation in health (muscle strength, learning and memory) and disease (neuromuscular and neuro-degenerative disorders).〔("The creatine kinase system and pleiotropic effects of creatine" )〕 *The structure and molecular physiology of AMP-activated protein kinase (AMPK), involved in cellular energy homeostasis and nutritional signalling, which is relevant for type-2 diabetes, obesity, metabolic syndrome and cancer. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Theo Wallimann」の詳細全文を読む スポンサード リンク
|